Clinical trials have complex eligibility criteria.Always talk to your clinician about you’re interest in participating in a trial.Learn why
HP Version - Clinical trials have complex eligibility criteria.Always talk to your clinician about you’re interest in participating in a trial.Learn why
Optimise reading forHealth ProfessionalsPatients
RecruitingLast updated: 2 February 2024
Clinical summaryEligibilityParticipating hospitalsSupport
This trial has several arms (groups), and participants will be allocated based on their diagnosis.
This trial is treating patients with hepatoblastoma and hepatocellular carcinoma.
Upper gastrointestinal tract
>30
III
PHITT
Use the hyperlinks, where available to access additional clinical trial information.
University of Birmingham
Paediatric Hepatic International Tumour Trial
Share with email
Print this page
Download brochure
Clinical diagnosis of HB* and histologically defined diagnosis of HB or HCC.
*Histological confirmation of HB is required except in emergency situations where:
Clinical trials have complex eligibility criteria.
Ask your doctor if this trial could be right for you.
Tell us if you find this trial availability is not accurate.Report inaccuracy
Speak with someone who has cancer clinical trial experience.
Learn more
If you need cancer information and practical support for yourself, a carer, family or friend, contact Cancer Council’s experienced cancer nurses on 131120.
When you are considering a cancer clinical trial, it is a good idea to discuss it with your family, friends or carers.
Thank you for helping us to increase accuracy of the trial. Our team will validate the information and update the information as soon as possible.